- Previous Rank-
- Revenues ($M)$1,848
- Revenue Percent Change0.9%
- Profits ($M)$111.5
- Profits Percent Change-47.5%
- Assets ($M)$3,091
- Employees9,200
- Market Value — as of March 31, 2017 ($M)$3,534
Company Info
CEO | John R. Chiminski |
CEO Title | Chairman & Chief Executive Officer |
Sector | Health Care |
Industry | Pharmaceuticals |
HQ Location | Somerset, NJ |
Website | http://www.catalent.com |
Years on Fortune 500 List | - |
Employees | 9,200 |
Catalent Rank History
Key Financials (Last Fiscal Year)
$ millions | % change | |
---|---|---|
Revenues ($M) | $1,848 | 0.9% |
Profits ($M) | $111.5 | -47.5% |
Assets ($M) | $3,091 | - |
Total Stockholder Equity ($M) | $636 | - |
Market Value — as of March 31, 2017 ($M) | $3,534 | - |
Profit Ratios
Profit as % of Revenues | 6% |
Profits as % of Assets | 3.6% |
Profits as % of Stockholder Equity | 17.5% |
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($) | 0.89 |
EPS % Change (from 2015) | -49.1% |
EPS % Change (5 year annual rate) | - |
EPS % Change (10 year annual rate) | - |
Total Return
Total Return to Investors (2016) | 7.7% |
Total Return to Investors (5 year, annualized) | - |
Total Return to Investors (10 year, annualized) | - |